Abstract
Theaim of this studyis to evaluate theperiodontal status parameters in patients treated with with or without the adjuvant bevacizumab, to establish a correlation between the type of administered chemotherapy and periodontal status.
Author supplied keywords
Cite
CITATION STYLE
APA
Nitescu, D. C. K., Constantin, M., Oanta, C., Martu, I., Volovat, S. R., & Martu, S. (2017). Evaluation of cumulative effects of chemotherapy and bevacizumab (Avastin®) in oncological patients with periodontal disease. Revista de Chimie, 68(3), 549–552. https://doi.org/10.37358/rc.17.3.5499
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free